|
|
Browse products Anticancer agents in preclinical trials Anticancer molecular libraries Other drug agents
|
MedKoo product information:
AZD-6918
Description of AZD-6918:
Current developer: AstraZeneca.
Phase I clinical trial for AZD-6918 was started in 2009. However, AZD6918 was discontinued from development due to an unacceptable pharmacokinetic profile. Drug was discontinued in 2009.
|
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
||||||||||||||
About us | Services | Products | News | Careers | Contact us